- Home
- FTLF vs GNLX Comparison
FTLF vs GNLX Comparison
Compare FTLF & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTLF
- GNLX
- Stock Information
- Founded
- FTLF 2005
- GNLX 2001
- Country
- FTLF United States
- GNLX United States
- Employees
- FTLF N/A
- GNLX N/A
- Industry
- FTLF Medicinal Chemicals and Botanical Products
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- FTLF Health Care
- GNLX Health Care
- Exchange
- FTLF Nasdaq
- GNLX Nasdaq
- Market Cap
- FTLF 149.3M
- GNLX 128.0M
- IPO Year
- FTLF N/A
- GNLX 2023
- Fundamental
- Price
- FTLF $20.03
- GNLX $5.44
- Analyst Decision
- FTLF Strong Buy
- GNLX Strong Buy
- Analyst Count
- FTLF 2
- GNLX 4
- Target Price
- FTLF $23.00
- GNLX $17.75
- AVG Volume (30 Days)
- FTLF 15.8K
- GNLX 132.3K
- Earning Date
- FTLF 11-13-2025
- GNLX 11-13-2025
- Dividend Yield
- FTLF N/A
- GNLX N/A
- EPS Growth
- FTLF N/A
- GNLX N/A
- EPS
- FTLF 0.80
- GNLX N/A
- Revenue
- FTLF $63,053,000.00
- GNLX N/A
- Revenue This Year
- FTLF $34.34
- GNLX N/A
- Revenue Next Year
- FTLF $48.58
- GNLX N/A
- P/E Ratio
- FTLF $25.03
- GNLX N/A
- Revenue Growth
- FTLF 3.91
- GNLX N/A
- 52 Week Low
- FTLF $9.83
- GNLX $1.99
- 52 Week High
- FTLF $20.98
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- FTLF 57.48
- GNLX 68.50
- Support Level
- FTLF $19.76
- GNLX $4.17
- Resistance Level
- FTLF $20.77
- GNLX $5.72
- Average True Range (ATR)
- FTLF 0.48
- GNLX 0.38
- MACD
- FTLF -0.11
- GNLX 0.07
- Stochastic Oscillator
- FTLF 25.35
- GNLX 75.16
About FTLF FitLife Brands Inc.
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori, and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.